Objective: To investigate the effects of umbilical artery catheters (UACs) on superior mesenteric artery (SMA) blood flow velocity (BFV) following enteral feedings in very low birth weight preterm infants.
Introduction
The superior mesenteric artery (SMA) is the blood vessel that supplies the greatest volume of blood to the small intestine. The use of Doppler ultrasound to measure SMA blood flow velocity (BFV) is increasingly used to investigate intestinal hemodynamics in neonates. We 1 and others [2] [3] [4] [5] [6] have demonstrated that SMA BFV progressively increases during the first week of life in preterm infants, which likely reflects increasing maturation of the intestinal tract. Several clinical factors may impact SMA BFV in preterm neonates, including the initiation of enteral feedings, 6 -9 the administration of vasoactive medications, [10] [11] [12] [13] the administration of continuous positive airway pressure, 1 phototherapy 14, 15 and umbilical artery catherization. 16, 17 Umbilical artery catheterization is a procedure commonly performed in very low birth weight (VLBW) infants. Umbilical artery catheters (UACs) are used for routine monitoring of blood gases and chemistries, and for the administration of fluid and hyperalimentation if alternative access is not available. Intestinal disturbances such as abdominal distension, ischemia and necrotizing enterocolitis have been attributed to UACs. Postulated mechanisms include the release of thrombi by the UAC, and decreased blood flow to the SMA secondary to a reduction in the diameter of the lumen of the aorta. [18] [19] [20] However, the effect of UACs on SMA blood flow remains controversial; several investigators report that UACs have no effect on SMA blood flow, 21, 22 whereas others report that UACs are associated with reduced SMA blood flow. 16, 17 Neonatology practice guidelines reflect the controversy regarding UAC effects on intestinal hemodynamics. The guidelines for enteral feeding range from non-permissive, 23 to undecided 24 or supportive. 25 As alterations in intestinal perfusion may predispose an enterally fed infant to the development of necrotizing enterocolitis 26, 27 neonatologists are often hesitant to feed infants with UACs. A survey of neonatal intensive care directors in the US revealed that newborns with UACs in place receive enteral feedings most of the time (30%), some of the time (49%) or none of the time (22%). 28 Although the effect of UACs on SMA BFV has been investigated, albeit with conflicting results, we are not aware of studies that have investigated the effects of UACs on SMA BFV responses to enteral feedings. We investigated the effect of UACs on intestinal blood flow responses to feedings by measuring pre-and postprandial SMA BFV in VLBW neonates before and after UAC removal.
Patients and methods

Study design
In this prospective study, SMA BFV responses to feeding were measured while a UAC was in place, and in the same infants after the UAC was removed. On the day the UAC was scheduled to be removed, pre-and postprandial SMA BFV measurements were made in conjunction with a minimal enteral feeding given while the UAC was in place (Study 1). The same measurements were made with the next feeding that was given after the UAC was removed (Study 2). Preprandial measurements were made at least 3 h after the last feeding, and postprandial measurements were made 30, 45 and 60 min after the feeding began. The same type and volume of feeding were used for Studies 1 and 2.
Subjects
Infants admitted to the NICU at Tampa General Hospital and who had UACs inserted according to standard clinical care guidelines were eligible for enrollment. Additional inclusion criteria were birth weight <1 500 g, birth weight appropriate for gestational age, cardiovascular and hemodynamic stability, and postnatal age p2 days. Exclusion criteria were clinical evidence of major congenital anomalies or congenital heart disease, and a diagnosis of anemia (venous hemoglobin (Hgb) <10 g/dl) or polycythemia (venous Hgb>22 g/dl). Infants who, in the opinion of the attending neonatologist, would not tolerate enteral feeds were also excluded.
This study was approved by the University of South Florida Institutional Review Board for the Protection of Human Subjects. Informed consent was obtained from the parent(s) of all enrolled infants.
Standard clinical care
All enrolled infants received standard clinical care for our NICU, which includes enteral feedings for most infants with UACs. UACs were inserted in the 'high' position (tip at the T 6 to T 9 level) within 2 to 3 h after birth. UACs remained in place for 3 to 7 days. Small amounts of preterm infant formula or unfortified human milk were given by nasogastric tube within the first 48 h of life. The rate of increase of the feedings (typically 15 to 20 ml/kg/day) was based on signs of feeding intolerance. UACs were removed at the discretion of the attending neonatologist. Mean arterial pressure with the UAC in place was measured invasively via the umbilical artery, whereas pressures with the UAC removed were recorded using a blood pressure cuff.
Doppler ultrasound studies SMA BFV was measured using pulsed Doppler ultrasound (Acuson Sequoia C512, Mountainview, CA, USA) and a 10.0 MHz transducer. The sampling volume of the pulsed Doppler was placed 3 mm distal to the origin of the SMA using a real-time two-dimensional image from a longitudinal abdominal approach. When five stable consecutive waveforms were obtained, the curve was traced and the mean velocity, mean peak systolic flow velocity and mean end diastolic flow velocity were recorded. All measurements were performed by one of two ultrasound technicians.
Statistical analyses
A t-test for paired samples would require 20 completed subjects to detect a 40% difference in peak postprandial SMA BFV with the UAC in place compared with the UAC removed (two-tailed, a ¼ 0.05, b ¼ 0.80). Regression analysis was used to measure the relationship between SMA BFV (baseline and postprandial change from 0 to 45 min) and the presence of a patent ductus arteriosus (PDA), the administration of caffeine, phototherapy or ventilation support. A two-way paired-samples t-test was used to analyze differences in preprandial SMA BFV and physiologic measurements between Studies 1 and 2. A repeated-measures analysis of variance (ANOVA) was used to measure the significance of changes in SMA BFV from 0 to 45 min. Wilcoxon signed ranks test for two related samples was used to compare differences in the percent increase from baseline to maximum SMA BFV with the UAC in place compared with the UAC removed. SPSS (SPSS Inc., Version 14.0, Chicago, IL, USA) was used for all analyses. Data represent the mean±s.d. unless otherwise indicated.
Results
Twenty-one infants were enrolled. Two infants had increased gastric residuals and moderate bowel distension after SMA BFV measurements were made with the UAC in place. Feedings were withheld from these infants for more than 12 h, and the infants were withdrawn from the study. The mean birth weight and gestational age of the remaining 19 infants were 1014±221 g and 27.4±1.9 weeks, respectively ( Table 1) . During hospitalization, two (11%) infants developed necrotizing enterocolitis (XBell Stage 2), five (26%) developed intraventricular hemorrhage (three infants with XGrade III) and three (16%) developed bronchopulmonary dysplasia. Infants reached full enteral feedings (150 ml/kg/day) at a median age of 22 days (range 14 to 93), and the median length of hospitalization was 60 days (range 24 to 210).
Infants were 4.6±1.7-days-old when SMA BFV measurements were made with the UAC in place. At that time, infants were being fed every 3 (n ¼ 8), 6 (n ¼ 9) or 12 (n ¼ 2) h. The time between Studies 1 and 2 was 4.7±3.2 h. The mean feeding volume given for measurements made with the UAC in place and with the UAC removed was 1.3±0.6 ml. Clinical variables that may affect SMA BFV are listed in Table 1 . For each subject, these variables did not change between Studies 1 and 2, with the exception of one infant whose umbilical venous catheter was removed between Studies 1 and 2. Preprandial SMA BFV and selected physiologic variables were similar at the time Studies 1 and 2 were performed ( Table 2) . Ventilation settings, including the amount of supplemental oxygen administered, were the same for measurements made with the UAC in place and with the UAC removed.
There was a significant positive correlation (P<0.05) between the volume of enteral feeding and the percent increase in peak systolic velocity (PSV), mean velocity (MV) and end-diastolic velocity (EDV). As reported by others, 7, 29, 30 peak postprandial SMA BFV generally occurred 45 min after feedings began, with the exception of EDV with the UAC out (Figures 1-3) . Although postprandial increases were greater with the UAC in place, pairwise comparisons revealed that the percent increase from baseline to 45 min was not significantly different between Studies 1 and 2 (Table 3) .
Phototherapy was associated with significantly lower mean and PSV at baseline (P<0.05), both with the UAC in place and with the UAC removed. The presence of a PDA was associated with significantly lower EDV at baseline (P<0.03), both with the UAC in place and with the UAC removed (data not shown). Phototherapy, the presence of a PDA, ventilation, caffeine administration and the type of feeding given did not affect the change in SMA BFV from 0 to 45 min. SMA BFVs for the two infants who developed necrotizing enterocolitis at 2 weeks of age were not markedly different from those of the other infants in the study.
Discussion
In the present study, the presence of a UAC did not have a significant effect on the SMA BFV response to minimal enteral feedings. We also report that preprandial SMA BFV was not affected by the presence of a UAC -a finding that is in agreement with other investigators. Roll et al. 21 measured SMA BFV before and 30 to 60 min after removal of the UAC in neonates whose median birth weight was 1180 g; none of the infants were receiving enteral feedings. The UAC s were in the high position (T6 to T10), and the mean age at removal was 4 days (range 1 to 9 days). There were no differences in SMA BFV before and after removal of the UAC. Shah et al. 22 measured SMA BFV immediately before and 2.6 h after removal of a UAC in infants with birth weights of 450 to 2520 g. Over half of the infants were being fed enterally (mean volume 9.8 ml), and measurements were made more than 1.5 h after an enteral feeding. There were no significant differences in BFV before and after UAC removal. These studies are in contrast to that of Rand et al., 17 who measured SMA BFV before and 30 to 60 min after removal of the UAC in newborns with a mean birth weight of 2003 g. The authors do not indicate whether the infants were being fed enterally. The UACs were in the high position (tip above the celiac trunk), and were in place for a mean of 9 days. PSV with the UAC in place was 20 cm/s lower (P<0.05) than with the UAC removed.
The studies described above addressed the effects of UACs on SMA BFV in the unfed or preprandial state. We are not aware of studies that have investigated the effects of UACs on SMA BFV responses to enteral feedings. In our study, there were no significant differences in SMA BFV responses to minimal enteral feedings in infants with a UAC in place compared with the same infants with the UAC removed. Other clinical factors, including the type of feeding given, phototherapy, the presence of a PDA, caffeine administration and ventilation support, did not significantly affect the postprandial change in SMA BFV.
As reported by others 31, 32 baseline velocities were lower in infants with a PDA and in infants undergoing phototherapy. 14, 15 Ongoing studies are designed to identify additional factors that affect baseline and postprandial SMA BFV responses, and to further describe the relationship between SMA BFV and clinical outcomes.
Delays in the introduction of enteral feedings are a major cause of postnatal growth restriction, which is the most common morbidity in VLBW preterm infants. 33, 34 Enteral feeding is essential for the promotion of intestinal maturation and growth, as it increases intestinal blood flow, stimulates intestinal motility and induces the release of trophic factors. 35 Although the relationship between SMA BFV, intestinal microcirculation and the development of bowel pathologies in neonates is unclear, necrotizing enterocolitis is reportedly associated with alterations in SMA BFV. 26, 27 For this reason, neonatologists are often hesitant to feed infants with UACs. However, our results indicate that the presence of a UAC does not affect postprandial SMA BFV responses to minimal enteral feedings, and suggest that concerns about mesenteric artery blood flow should not limit the use of minimal enteral feedings in VLBW infants with UACs. 
